APTEVO THERAPEUTICS INC (APVO) Stock Analyst Ratings
USA - NASDAQ:APVO - US03835L5049 - Common Stock
1.4101 USD
+0.01 (+0.72%)
ChartMill assigns a Buy % Consensus number of 83% to APVO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 428.4. This target is 30280.82% above the current price.
APVO was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about APVO.
In the previous month the buy percentage consensus was at a similar level.
APVO was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-09-23 | Roth MKM | Maintains | Buy -> Buy |
| 2022-05-13 | Piper Sandler | Maintains | Overweight |
| 2021-05-28 | Roth Capital | Maintains | Buy |
APTEVO THERAPEUTICS INC / APVO FAQ
What is the price target for APVO stock?
7 analysts have analysed APVO and the average price target is 428.4 USD. This implies a price increase of 30280.82% is expected in the next year compared to the current price of 1.4101.
Can you provide the consensus rating for APTEVO THERAPEUTICS INC stock?
The consensus rating for APTEVO THERAPEUTICS INC (APVO) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.